Indonesia vs Latvia: Treatment success rate: XDR-TB cases

Indonesia
53
in 2022
Latvia
50
in 2015
Indonesia rank
59th
Latvia rank
61st

Treatment success rate: XDR-TB cases over time

  • Indonesia
  • Latvia
20406080200820152022

How they compare

Indonesia currently reports 53 against 50 in Latvia, a difference of 3.

That makes Indonesia's figure about 1.1 times Latvia's.

The two have swapped places 1 time across 5 shared years of data; in 2011 it was Indonesia ahead.

Indonesia ranks 59th and Latvia ranks 61st of 82 countries.

Latvia has averaged higher in every one of the 1 decades both report.

Frequently asked questions

Which has higher treatment success rate: xdr-tb cases, Indonesia or Latvia?
Indonesia, at 53 against 50 in Latvia as of 2022.
What is the difference in treatment success rate: xdr-tb cases between Indonesia and Latvia?
3, with Indonesia ahead.
How many years of comparable data are there for Indonesia and Latvia?
5 years are reported by both, from 2011 to 2015.
How do Indonesia and Latvia rank globally for treatment success rate: xdr-tb cases?
Indonesia ranks 59th and Latvia ranks 61st of 82 countries.
Where does this data come from?
World Health Organization, Global Health Observatory, published as Treatment success rate: XDR-TB cases. Statizoid refreshes it automatically from the source and publishes the full history for both places.

Individual pages

Share, cite or embed this page

Cite this page

Indonesia vs Latvia: Treatment success rate: XDR-TB cases. Statizoid, drawing on World Health Organization, Global Health Observatory. Retrieved 02 September 2026, from https://health.statizoid.com/compare/treatment-success-rate-xdr-tb-cases/indonesia/latvia/

Embed or link this data

Paste this into a page to link back to these figures. The data itself is free to reuse under CC BY-NC-SA 3.0 IGO (WHO); please keep the attribution.

<a href="https://health.statizoid.com/compare/treatment-success-rate-xdr-tb-cases/indonesia/latvia/">Indonesia vs Latvia: Treatment success rate: XDR-TB cases</a> — Statizoid

About this data

Indicator
Treatment success rate: XDR-TB cases
Source
World Health Organization, Global Health Observatory
Licence
CC BY-NC-SA 3.0 IGO (WHO)
Coverage
93 places, 901 data points, 2008–2022
Last refreshed